Ghost Authorship in Industry-Initiated Randomised Trials
نویسندگان
چکیده
منابع مشابه
Ghost Authorship in Industry-Initiated Randomised Trials
BACKGROUND Ghost authorship, the failure to name, as an author, an individual who has made substantial contributions to an article, may result in lack of accountability. The prevalence and nature of ghost authorship in industry-initiated randomised trials is not known. METHODS AND FINDINGS We conducted a cohort study comparing protocols and corresponding publications for industry-initiated tr...
متن کاملHonorary and ghost authorship in nursing publications.
PURPOSE The purposes of this study were to (a) assess the prevalence of articles with honorary authors and ghost authors in 10 leading peer-reviewed nursing journals between 2010 to 2012; (b) compare the results to prevalence reported by authors of articles published in high-impact medical journals; and (c) assess the experiences of editors in the International Academy of Nursing Editors with h...
متن کاملOpen Medicine’s ghost and guest authorship policy
The authors are on the editorial team of Open Medicine. G host authorship occurs when someone makes a significant contribution to a manuscript without due acknowledgement of their role. Guest authorship , in contrast, occurs when an individual is named as an author of a manuscript when they do not meet authorship criteria. Both are disturbingly common. 1 The preliminary results of a recent surv...
متن کاملIntroducing “Agreement on what to Measure in Randomised Controlled Trials in Burn Care” Research Project
پروژه پژوهشی "توافق درباره‌ی پیامدهای قابل اندازه‌گیری در کارآزمایی های کنترل‌دار مربوط به مراقبت‌های سوختگی" توسط گروهی از پژوهش‌گران با تجربه، در حوزه سوختگی، زیر نظر دکتر Young از کشور انگلستان در حال انجام می‌باشد. هدف نهایی از انجام این مطالعه، تهیه و تدوین مجموعه‌ای از پیامدهای اساسی (core outcome set (COS)) است که در گزارش کارآزمایی های شاهد‌دار تصادفی مربوط به مراقبت‌های سوختگی باید مور...
متن کاملInstitution/investigator-initiated clinical trials in Canada.
Institution/investigator-initiated clinical trials in Canada require adherence to similar regulations and processes required of large pharmaceutical manufacturers. This may require an investigator to file a Clinical Trial Application. This article outlines the responsibilities and actions that are required prior to, during, and after the conduct of an institution/investigator initiated trial.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLoS Medicine
سال: 2007
ISSN: 1549-1676
DOI: 10.1371/journal.pmed.0040019